Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
776
DELISTED
Mersana Therapeutics
MRSN
| $18.2M | 0.02% |
31,078
+10,546
| +51% | +$3.6M |
|
777
Dentsply Sirona
XRAY
$2.17B
| $18.2M | 0.02% |
412,438
+162,733
| +65% | +$6.88M |
|
|
TXNM
778
TXNM Energy Inc
TXNM
$5.88B
| $18.1M | 0.02% |
472,051
+69,238
| +17% | +$2.77M |
|
779
United Airlines
UAL
$36.9B
| $18.1M | 0.02% |
523,814
-439,594
| -46% | -$13.2M |
|
780
Globe Life
GL
$13.3B
| $18.1M | 0.02% |
244,200
+55,043
| +29% | +$4.18M |
|
781
UWM Holdings
UWMC
$2.28B
| $18M | 0.02% |
+1,779,500
| New | +$17.8M |
|
782
Stratasys
SSYS
$670M
| $18M | 0.02% |
1,135,287
+1,116,008
| +5,789% | +$18.9M |
|
783
PUT
Eli Lilly
LLY
$1.11T
| $18M | 0.02% |
109,600
-131,500
| -55% | -$20.2M |
|
784
Mine Safety
MSA
$7.29B
| $18M | 0.02% |
157,093
+147,807
| +1,592% | +$16.4M |
|
785
Rogers Communications
RCI
$19.7B
| $18M | 0.02% |
447,266
+235,617
| +111% | +$9.81M |
|
|
ADAP
786
DELISTED
Adaptimmune Therapeutics
ADAP
| $17.9M | 0.02% |
1,787,604
+331,725
| +23% | +$2.08M |
|
787
T. Rowe Price
TROW
$24B
| $17.9M | 0.02% |
+144,630
| New | +$16.5M |
|
788
Cracker Barrel
CBRL
$1.3B
| $17.8M | 0.02% |
160,934
+43,760
| +37% | +$4.34M |
|
789
CALL
Humana
HUM
$46.4B
| $17.8M | 0.02% |
+46,000
| New | +$17.2M |
|
|
PRAH
790
DELISTED
PRA Health Sciences, Inc.
PRAH
| $17.8M | 0.02% |
+183,211
| New | +$17M |
|
|
TREB.U
791
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
| $17.8M | 0.02% |
+1,700,000
| New | +$17.7M |
|
792
CALL
Qualcomm
QCOM
$166B
| $17.7M | 0.02% |
+194,200
| New | +$15.6M |
|
793
B&G Foods
BGS
$284M
| $17.7M | 0.02% |
724,861
+183,202
| +34% | +$3.97M |
|
794
CNX Resources
CNX
$5.4B
| $17.6M | 0.02% |
2,040,270
+1,474,170
| +260% | +$14.8M |
|
795
CALL
Thermo Fisher Scientific
TMO
$232B
| $17.5M | 0.02% |
48,400
+38,400
| +384% | +$12.9M |
|
796
Louisiana-Pacific
LPX
$5.08B
| $17.5M | 0.02% |
682,791
-2,145,825
| -76% | -$45.4M |
|
797
ITT
ITT
$18.3B
| $17.5M | 0.02% |
298,100
-52,938
| -15% | -$2.81M |
|
|
BMCH
798
DELISTED
BMC Stock Holdings, Inc
BMCH
| $17.4M | 0.02% |
+693,788
| New | +$15.4M |
|
799
CareTrust REIT
CTRE
$9.37B
| $17.4M | 0.02% |
1,016,137
+377,184
| +59% | +$6.59M |
|
800
Huntington Ingalls Industries
HII
$11.6B
| $17.4M | 0.02% |
+99,467
| New | +$18.5M |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.